ESC Premium Access

Optimal surrogate endpoints of drug response

Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy
Session type: Moderated Posters
Date: 26 August 2018
Time: 15:50 - 16:40

Congress Session

6 presentations in this session

The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy

Speaker: Doctor K. Tsuchida (Niigata, JP)

Interaction of statin therapy to angiotensin ii receptor type 1 blockers in erectile dysfunction patients. effect on endothelial function and aortic stiffness

Speaker: Doctor N. Ioakeimidis (Athens, GR)

Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics

Speaker: Doctor J. Leeds (South San Francisco, US)

Acute and chronic effect of ticagrelor versus clopidogrel on aortic stiffness

Speaker: Associate Professor C. Vlachopoulos (Athens, GR)

Cilostazol induces regression of carotid plaque in patients with high cardiovascular risk: CLOVER study. A multicenter, randomized trial.

Speaker: Professor K. Cho (Busan, KR)

Ticagrelor reduced CD40L level in patient with ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention compared with clopidogrel

Speaker: Doctor Z. Li (Jinan, CN)

6 speakers from this session

Doctor Keiichi Tsuchida

Niigata City General Hospital, Niigata (Japan)
0 follower

Doctor Nikolaos Ioakeimidis

University of Athens, Athens (Greece)
0 follower

Doctor Janet Leeds

, South San Francisco (United States of America)
0 follower

Associate Professor Charalambos Vlachopoulos

National & Kapodistrian University of Athens, Athens (Greece)
16 presentations
0 follower

Professor Kyoung Im Cho

Maryknoll Medical Center, Busan (Korea (Republic of))
0 follower

Doctor Zhenhua Li

Jinan Central Hospital, Jinan (China)
0 follower

This platform is supported by

logo Novo Nordisk